Literature DB >> 16683115

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.

W De Wever1, S Ceyssens, L Mortelmans, S Stroobants, G Marchal, J Bogaert, J A Verschakelen.   

Abstract

Integrated positron emission tomography (PET) and computed tomography (CT) is a new imaging modality offering anatomic and metabolic information. The purpose was to evaluate retrospectively the accuracy of integrated PET-CT in the staging of a suggestive lung lesion, comparing this with the accuracy of CT alone, PET alone and visually correlated PET-CT. Fifty patients undergoing integrated PET-CT for staging of a suggestive lung lesion were studied. Their tumor, node, metastasis (TNM) statuses were determined with CT, PET, visually correlated PET-CT and integrated PET-CT. These TNM stages were compared with the surgical TNM status. Integrated PET-CT was the most accurate imaging technique in the assessment of the TNM status. Integrated PET-CT predicted correctly the T status, N status, M status and TNM status in, respectively, 86%, 80%, 98%, 70% versus 68%, 66%,88%, 46% with CT, 46%, 70%, 96%, 30% with PET and 72%, 68%, 96%, 54% with visually correlated PET-CT. T status and N status were overstaged, respectively, in 8% and 16% with integrated PET-CT, in 20% and 28% with CT, in 16% and 20% with PET, in 12% and 20% with visually correlated PET-CT and understaged in 6% and 4% with integrated PET-CT, versus 12% and 6% with CT, 38% and 10% with PET and 12% with visually correlated PET-CT. Integrated PET-CT improves the staging of lung cancer through a better anatomic localization and characterization of lesions and is superior to CT alone and PET alone. If this technique is not available, visual correlation of PET and CT can be a valuable alternative.

Entities:  

Mesh:

Year:  2006        PMID: 16683115     DOI: 10.1007/s00330-006-0284-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.

Authors:  Suzanne L Aquino; Jane C Asmuth; Nathaniel M Alpert; Elkan F Halpern; Alan J Fischman
Journal:  J Comput Assist Tomogr       Date:  2003 Jul-Aug       Impact factor: 1.826

Review 2.  PET/CT scanners: a hardware approach to image fusion.

Authors:  David W Townsend; Thomas Beyer; Todd M Blodgett
Journal:  Semin Nucl Med       Date:  2003-07       Impact factor: 4.446

3.  FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients.

Authors:  P Magnani; A Carretta; G Rizzo; F Fazio; A Vanzulli; G Lucignani; P Zannini; C Messa; C Landoni; M C Gilardi; A Del Maschio
Journal:  J Cardiovasc Surg (Torino)       Date:  1999-10       Impact factor: 1.888

4.  Detection of extrathoracic metastases by positron emission tomography in lung cancer.

Authors:  W Weder; R A Schmid; H Bruchhaus; S Hillinger; G K von Schulthess; H C Steinert
Journal:  Ann Thorac Surg       Date:  1998-09       Impact factor: 4.330

5.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

6.  Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?

Authors:  K U Juergens; M Weckesser; L Stegger; C Franzius; M Beetz; O Schober; W Heindel; D Wormanns
Journal:  Eur Radiol       Date:  2006-02-01       Impact factor: 5.315

7.  FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; S G Stroobants; P J Dupont; P R De Leyn; W F De Wever; E K Verbeken; J L Nuyts; F P Maes; J G Bogaert
Journal:  Eur J Nucl Med       Date:  1998-11

8.  PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Authors:  Zohar Keidar; Nissim Haim; Luda Guralnik; Mirjana Wollner; Rachel Bar-Shalom; Alon Ben-Nun; Ora Israel
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography.

Authors:  W J Scott; L S Gobar; J D Terry; N A Dewan; J J Sunderland
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

View more
  36 in total

1.  Multi slice computed tomography in the study of pulmonary metastases.

Authors:  G Angelelli; V Grimaldi; F Spinelli; A Scardapane; A Sardaro
Journal:  Radiol Med       Date:  2008-09-08       Impact factor: 3.469

Review 2.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 3.  The role of endobronchial ultrasound versus mediastinoscopy for non-small cell lung cancer.

Authors:  Katarzyna Czarnecka-Kujawa; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  A study on usefulness evaluation of SUV measured in mini-PACS for each one of PET/CT equipment.

Authors:  Seung-Yong Park; Ho-Sung Kim; Hyeon-Je Song; Kyung-Rae Dong; Woon-Kwan Chung; Hwa-Yeon Yeo
Journal:  J Digit Imaging       Date:  2015-02       Impact factor: 4.056

Review 5.  Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.

Authors:  Poul Henning Madsen; Paw Christian Holdgaard; Janne Buck Christensen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-11       Impact factor: 9.236

Review 6.  Role of positron emission tomography-computed tomography in non-small cell lung cancer.

Authors:  Pankaj Kumar Garg; Saurabh Kumar Singh; Gaurav Prakash; Ashish Jakhetiya; Durgatosh Pandey
Journal:  World J Methodol       Date:  2016-03-26

Review 7.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

8.  Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.

Authors:  Sandra Pauls; Andreas K Buck; Gisela Halter; Felix M Mottaghy; Rainer Muche; Christina Bluemel; Susanne Gerstner; Stefan Krüger; Gerhard Glatting; Ludger Sunder-Plassmann; Peter Möller; Hans-Jürgen Brambs; Sven N Reske
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

Review 9.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

Review 10.  Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Tomonori Kanda; Tomohiko Yamane; Tetsuya Tsujikawa; Hayato Kaida; Yukihisa Tamaki; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-04-27       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.